Quarterly report pursuant to Section 13 or 15(d)

Document And Entity Information

v3.19.2
Document And Entity Information - shares
6 Months Ended
Apr. 30, 2019
Jun. 11, 2019
Document and Entity Information [Abstract]    
Entity Registrant Name Anixa Biosciences Inc  
Document Type 10-Q  
Current Fiscal Year End Date --10-31  
Entity Common Stock, Shares Outstanding   20,096,743
Amendment Flag false  
Entity Central Index Key 0000715446  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Apr. 30, 2019  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Ex Transition Period false